The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference36 articles.
1. The role of regional chemotherapy in the management of extremity soft tissue malignancies;Smith;Eur J Surg Oncol,2016
2. Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters;Alexander;J Clin Oncol Offic J Am Soc Clin Oncol,2010
3. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience;Eggermont;Ann Surg,1996
4. In-transit Merkel cell carcinoma treated with isolated limb perfusion or isolated limb infusion: a case series of 12 patients;Zeitouni;Dermatol Surg Offic Publ Am Soc Dermatol Surg et al,2011
5. Isolated limb perfusion using tumour necrosis factor alpha and melphalan in patients with advanced aggressive fibromatosis;van Broekhoven;Br J Surg,2014
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Isolated limb perfusion for locally advanced melanoma in the immunotherapy era;European Journal of Surgical Oncology;2022-06
2. Frailty in Very Elderly Patients is Not Associated with Adverse Surgical or Oncological Outcomes in Extremity Surgery for Soft Tissue Sarcoma;Annals of Surgical Oncology;2022-02-03
3. Risk factors for the development of local recurrence in extremity soft-tissue sarcoma;Expert Review of Anticancer Therapy;2021-12-06
4. Neoadjuvant Use of Isolated Limb Perfusion in Large Myxoid Liposarcoma of the Thigh: a Case Report;Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca;2021-08-15
5. Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007–2018;Melanoma Research;2021-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3